Stocks At 52-Week Lows: Tuesday’s Full List
A large technology name leads a short list of stocks hitting yearly lows, raising questions about growth and price.
Biotechnology leads a small group of industries hitting new lows on Tuesday. In total, 15 stocks from the Russell 3000 are at their weakest price of the last year, a list led by AppLovin (APP) with a market value of about $107.5 billion. Its 28.0% decline over the last month stands out, especially as the S&P 500 has returned +2.9% over the same period.
The central question for a list like this is whether a steep, recent decline in a large-cap name signals damage or a discount. The full list of names follows.
The Full List, Largest First
The table below lists every stock at its 52-week low, largest first, with one-day, one-week, one-month, and one-year returns:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| APP | $107.5 Bil | -6.0% | -24.1% | -28.0% | -30.1% |
| ONON | $19.7 Bil | -20.3% | -17.8% | -18.5% | -32.3% |
| RBA | $16.7 Bil | -4.5% | -19.3% | -17.6% | -20.8% |
| WING | $3.1 Bil | -5.2% | -8.3% | -27.7% | -64.5% |
| ALHC | $2.7 Bil | -4.2% | -2.4% | -35.2% | -9.0% |
| EMAT | $1.4 Bil | -8.3% | -19.9% | -57.7% | n/a |
| UVV | $1.2 Bil | -2.5% | -12.4% | -9.3% | -6.0% |
| PLTK | $1.0 Bil | -4.6% | -34.2% | -35.0% | -25.8% |
| WVE | $1.0 Bil | -16.9% | -15.9% | -15.2% | -37.6% |
| ARDX | $1.0 Bil | -1.5% | -21.4% | -23.3% | -24.4% |
| LZ | $1.0 Bil | -4.2% | -35.2% | -29.5% | -50.5% |
| COLL | $0.8 Bil | -4.5% | -27.3% | -25.4% | -25.6% |
| ESRT | $0.8 Bil | -0.2% | -6.3% | -16.4% | -34.0% |
| CSV | $0.5 Bil | -1.8% | -17.0% | -14.4% | -29.4% |
| AMSF | $0.5 Bil | -0.4% | -5.9% | -20.6% | -32.9% |
Some names on the list still show strong business growth.
AppLovin (APP) is the largest company on the list, and its business fundamentals contrast with its stock price. The company’s revenue grew 60.6% over the last twelve months, and it trades at 24.3 times trailing earnings with a free cash flow yield of 4.2%. Elsewhere, Alignment Healthcare (ALHC) also pairs a new low with recent expansion, showing revenue growth of 37.2% over the last twelve months and a free cash flow yield of 6.5%.
A low price is a starting point, not a conclusion.
A 52-week-low list is a screen for dislocation, not a simple shopping list. A stock arrives here for a reason, and the price alone does not distinguish between a permanently impaired business and a temporarily marked-down one. The disciplined move is to treat the list as a prompt to check the underlying business fundamentals before reacting to the price chart.
If any of these names tempt you, resist buying a price alone. Our Buy the Dip screen asks the follow-up question that matters: which marked-down stocks still have the growth and cash generation to recover.
Weakness Is Information. It Is Not An Instruction
A 52-week low tells you what the market thinks today. It does not tell you what to do, and acting on price alone is how value traps get bought. The missing ingredient is always the same: is the business still sound?
Asking that question across thousands of stocks, every day, is exactly how the Trefis High Quality (HQ) Portfolio is built: roughly 30 names that pass the quality screens, held with rules instead of nerve. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the low list sharpen your watchlist, and let the portfolio carry the risk.